Clinical Trial: Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy
Study Status: Completed
Recruit Status: Completed
Condition: Gastric Cancer
Study Type: Observational [Patient Registry]
Official Title: Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy and Postoperative Adjuvant Chemotherapy Benefit in Advanced Gastric Cancer: a Two-center Study
Brief Summary:
Neoadjuvant chemotherapy (NC) is an important treatment for advanced gastric cancer (AGC). However, tools that effectively predict the efficacy of NC before treatment are lacking. Computed tomography images before and after NC were used to construct a deep learning-based radiomics signature to predict the efficacy of NC, prognoses and postoperative adjuvant chemotherapy benefit.
Read more